West Pharmaceutical Services, Inc. (NYSE:WST) headquartered in Exton, will host a conference call for the investment community to discuss the 3Q20 financial results on 22nd October 2020 at 9:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.westpharma.com
Earnings Expectation
West Pharmaceutical Services, Inc. is expected to report third quarter earnings results, before market open, on Thursday 22nd October 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.99 per share from revenue of $ 510.14 million. Looking ahead, the full year income are expected at $ 4.25 per share on the revenues of $ 2049.28 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 2,035.00 million ~ $ 2,055.00 million, where as bottomline are predicted in a range of $ 4.15 ~ $ 4.25 per share
Click Here For More Historical Outlooks Of West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
